34,970 research outputs found

    The collapse of single bubbles and approximation of the far-field acoustic emissions for cavitation induced by shock wave lithotripsy

    No full text
    Recent clinical trials have shown the efficacy of a passive acoustic device used during shock wave lithotripsy (SWL) treatment. The device uses the far-field acoustic emissions resulting from the interaction of the therapeutic shock waves with the tissue and kidney stone to diagnose the effectiveness of each shock in contributing to stone fragmentation. This paper details simulations that supported the development of that device by extending computational fluid dynamics (CFD) simulations of the flow and near-field pressures associated with shock-induced bubble collapse to allow estimation of those far-field acoustic emissions. This is a required stage in the development of the device, because current computational resources are not sufficient to simulate the far-field emissions to ranges of O(10 cm) using CFD. Similarly, they are insufficient to cover the duration of the entire cavitation event, and here simulate only the first part of the interaction of the bubble with the lithotripter shock wave in order to demonstrate the methods by which the far-field acoustic emissions resulting from the interaction can be estimated. A free-Lagrange method (FLM) is used to simulate the collapse of initially stable air bubbles in water as a result of their interaction with a planar lithotripter shock. To estimate the far-field acoustic emissions from the interaction, this paper developed two numerical codes using the Kirchhoff and Ffowcs William–Hawkings (FW-H) formulations. When coupled to the FLM code, they can be used to estimate the far-field acoustic emissions of cavitation events. The limitation of the technique is that it assumes that no significant nonlinear acoustic propagation occurs outside the control surface. Methods are outlined for ameliorating this problem if, as here, computational resources cannot compute the flow field to sufficient distance, although for the clinical situation discussed, this limitation is tempered by the effect of tissue absorption, which here is incorporated through the standard derating procedure. This approach allowed identification of the sources of, and explanation of trends seen in, the characteristics of the far-field emissions observed in clinic, to an extent that was sufficient for the development of this clinical device

    Prediction of far-field acoustic emissions from cavitation clouds during shock wave lithotripsy for development of a clinical device

    No full text
    This study presents the key simulation and decision stage of a multi-disciplinary project to develop a hospital device for monitoring the effectiveness of kidney stone fragmentation by shock wave lithotripsy (SWL). The device analyses, in real time, the pressure fields detected by sensors placed on the patient's torso, fields generated by the interaction of the incident shock wave, cavitation, kidney stone and soft tissue. Earlier free-Lagrange simulations of those interactions were restricted (by limited computational resources) to computational domains within a few centimetres of the stone. Later studies estimated the far-field pressures generated when those interactions involved only single bubbles. This study extends the free-Lagrange method to quantify the bubble–bubble interaction as a function of their separation. This, in turn, allowed identification of the validity of using a model of non-interacting bubbles to obtain estimations of the far-field pressures from 1000 bubbles distributed within the focus of the SWL field. Up to this point in the multi-disciplinary project, the design of the clinical device had been led by the simulations. This study records the decision point when the project's direction had to be led by far more costly clinical trials instead of the relatively inexpensive simulations. <br/

    PEMEROLEHAN BAHASA ANAK USIA DINI (AHMAD JAMALUDDIN MUTHOHAR) DI KABUBATEN BANYUWANGI

    No full text
    This research aims to describe Ahmad Jamaluddin Muthohar's language acquisition in the fields of phonology and syntax. This research is based on the speech of two year old children who are almost perfect in using word order and language. The method used is qualitative with a descriptive type, because this research contains language acquisition in early childhood which describes its acquisition in the areas of phonology and syntax. The results of research into the acquisition of phonology on consonants and vowels can be seen in the field of phonology which shows that Ahmad Jamaluddin Muthohar has mastered consonant letters and is able to pronounce them at the beginning, middle and end of words, but he has not mastered several consonants such as [r] and [ l] which he usually replaces with the consonant [n], and the consonant [v] is replaced with [p]. The consonants [w], [f], [y] have never been heard at the end of the word, the consonant [z] has only been heard at the beginning, while [x] has not been heard at all. The conclusion of this research is that Ahmad Jamaluddin Muthohar has obtained vowels that look perfect in their pronunciation and use at the beginning, middle and end of his words. Ahmad Jamaluddin Muthohar's acquisitions in the field of syntax can be seen in the use of declarative, interrogative and imperative sentences that he has mastere

    Modelling surface roughening during plastic deformation of metal crystals under contact shear loading

    No full text
    During plastic deformation, metal surfaces roughen and this has a deleterious impact on their tribological performance. It is therefore desirable to be able to predict and control the amount of roughening caused by subsurface plasticity. As a first step, we focus on modelling plastic deformation during contact shearing of an FCC metallic single crystal, employing a finite strain Discrete Dislocation Plasticity (DDP) formulation. This formulation allows us to capture the finite lattice rotations induced in the material by shearing and the corresponding local rotation of the crystallographic slip planes. The simulations predict a pronounced material pile-up in front of the contact and a sink-in at its rear, which are strongly crystal-orientation dependent. By comparing finite and small strain DDP, we can assess the effect of slip plane rotation on surface roughening and on metal plasticity in general. Results of the simulations are also compared with crystal plasticity, which is also capable of predicting a pile-up and sink-in, but not the crystal-orientation dependency of roughening.Accepted Author Manuscript(OLD) MSE-

    The Potential Economic Impacts of the Proposed Development Corridor in Egypt: An Interregional CGE Approach

    No full text
    Egypt has proposed a new development corridor. A main component is a desert-based expansion of the current highway network. This network is founded on a 1200-kilometer north-south route that starts at a proposed new port near El-Alemein and runs parallel to the Nile Valley to the border of Sudan. It also includes 21 east-west branches that connect the main axis to densely populated cities on the Nile. The paper is a first attempt at an economic assessment of the impact of this proposed corridor. It uses an interregional computable general equilibrium (CGE) model developed and reported in a prior paper. Here, that model is integrated with a more detailed geo-coded transportation network model to help quantify the spatial effects of transportation cost change due specifically to changes in accessibility induced by the corridor. The paper focuses on the likely structural economic impacts that such a large investment in transportation could enable through a series of simulations related to the operational phase of the project."TD NEREUS 06-2015" published by Núcleo de Economia Regional e Urbana da USP (NEREUS)

    N omega-nitro-L-arginine methyl ester inhibits inflammatory liver injury induced by interleukin-2

    No full text
    Administration of interleukin-2 (IL-2) for treatment of metastatic disease often results in inflammatory liver injury. Previous studies have implicated increased leukocyte and platelet adhesion and enhanced nitric oxide production as causative factors in the development of IL-2-induced hepatic injury. This study investigated the capacity of N omega-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthesis inhibitor, to limit IL-2-induced hepatic edema and hepatocellular damage in mice. Using hepatic intravital microscopy, we also examined the effects of L-NAME on IL-2-induced increases in leukocyte and platelet adhesion. Administration of IL-2 increased leukocyte and platelet adhesion in post-sinusoidal venules and decreased hepatic perfusion. Cotreatment with L-NAME had no effect on leukocyte adhesion but increased platelet-endothelial adhesion and microvascular thrombosis. Chronic IL-2 treatment induced hepatic edema and hepatocellular injury. However, coadministration of L-NAME attenuated IL-2-induced edema and completely inhibited hepatocellular damage. These findings suggest that nitric oxide may play a central role in IL-2-induced inflammatory liver injury.LR: 20061115; PUBM: Print; JID: 8405628; 0 (Enzyme Inhibitors); 0 (Interleukin-2); 10102-43-9 (Nitric Oxide); 50903-99-6 (NG-Nitroarginine Methyl Ester); EC 1.14.13.39 (Nitric Oxide Synthase); EC 2.6.1.1 (Aspartate Aminotransferases); EC 2.6.1.2 (Alanine Transaminase); ppublishSource type: Electronic(1

    Appropriate Similarity Measures for Author Cocitation Analysis

    No full text
    We provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis

    Combined application of ultrasonic waves, magnetic fields and optical flow in the rehabilitation of patients and disabled people

    No full text
    SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION PONTIFICAL CATHOLIC UNIVERSITY OF PERU RADOM UNIVERSITY SCM «MEDICAL INNOVATIVE TECHNOLOGIES» Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. COMBINED APPLICATION OF ULTRASONIC WAVES, MAGNETIC FIELDS AND OPTICAL FLOW IN THE REHABILITATION OF PATIENTS AND DISABLED PEOPLE Edited by Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. КIEV, RADOM 2016 SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION PONTIFICAL CATHOLIC UNIVERSITY OF PERU RADOM UNIVERSITY SCM «MEDICAL INNOVATIVE TECHNOLOGIES» Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. COMBINED APPLICATION OF ULTRASONIC WAVES, MAGNETIC FIELDS AND OPTICAL FLOW IN THE REHABILITATION OF PATIENTS AND DISABLED PEOPLE Edited by Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. КIEV, RADOM 2016 Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. Combined Application of Ultrasonic Waves, Magnetic Fields and Optical Flow in The Rehabilitation of Patients and Disabled People. Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. Eds. Shupyk National Medical Academy of Postgraduate Education. Pontifical Catholic University of Peru. Radom University. SCM «Medical Innovative Technologies». Kiev. Radom. 308 p. ISBN 9781365244537. DOI http://dx.doi.org/10.5281/zenodo.57246 UDC 615.847.8+615.837 LBC: 53.54 Reviewers: prof. zw. dr hab. med. L. Tondiy (Ukraine), MD, Professor L. Tondiy prof. zw. dr hab. med. V. Gubenko (Ukraine), MD, Professor V. Gubenko prof. zw. dr hab. med. A. Kozhanova (Ukraine), MD, Professor A. Kozhanova Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. Combined application of ultrasonic waves, magnetic fields and optical flow in the rehabilitation of patients and disabled people. Edited by Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. Kiev. Radom. – 2016. – 308 p. UDC 615.847.8+615.837 LBC: 53.54 Memory of the great scientist Professor Ivan Zakharovich Samosyuk dedicated. The book presents modern data on the use of a resonant magnetic therapy, ultrasound and magnetic-laser effects. Describes practical techniques of the combined and the united use of these physical factors in the different sections of clinical medicine (neurology, cardiology, gastroenterology, gynecology, etc.). The book also describes the modern principles of selecting impact zones, the rationale biorhythmological and resonance effects, the practical use of which is becoming increasingly important in physiotherapy and physiopuncture. Most private techniques of magnet-laser-ultrasound therapy are described with respect to a new generation of devices of «MIT» series and the «MIT-11», which contains all three of these factors: ultrasound, magnetic field and laser radiation. The book is intended for physical therapists, rehabilitation specialists, health resort, the doctors of narrow specialties, using methods of physiotherapy, as well as nurses rehabilitation centers, beauty parlor and a wide range of readers interested in the problems of sanitation. Authors are grateful to Alla Tereshchenko, Yevheniya Gorlatenko and Olga Danilova for their assistance in the preparation for publication of the monograph. © The Author(s) 2016. This articles is published with Open Access. Medical Innovative Technologies, Kiev, Ukraine and Radomska Szkoła Wyższa w Radomiu, Poska, Radom University in Radom, Poland. Open Access This articles is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. Attribution — You must attribute the work in the manner specified by the author or licensor (but not in any way that suggests that they endorse you or your use of the work). Noncommercial — You may not use this work for commercial purposes. Share Alike — If you alter, transform, or build upon this work, you may distribute the resulting work only under the same or similar license to this one. Zawartość jest objęta licencją Creative Commons Uznanie autorstwa-Użycie niekomercyjne-Na tych samych warunkach 3.0 Publishing House: Radomska Szkoła Wyższa w Radomiu, Radom University in Radom Str. Zubrzyckiego 2 26-600 Radom Tel.: +48 48 383 66 05 [email protected] Printing House: Radomska Szkoła Wyższa w Radomiu, Radom University in Radom Str. Zubrzyckiego 2 26-600 Radom Tel.: +48 48 383 66 05 [email protected] ISBN 9781365244537 DOI http://dx.doi.org/10.5281/zenodo.57246 308 s. Liczba znaków: 478 000 (ze streszczeniami i okładką). Liczba grafik: 136 x 1 000 znaków (ryczałt) = 136 000 znaków. Razem: Liczba znaków: 614 000 (ze streszczeniami, okładką i grafikami) = 15,35 arkuszy wydawniczych. 308 p. Number of characters: 248 000 (with abstracts). Number of images: 136 x 1000 characters (lump sum) = 136 000 characters. Total: Number of characters: 614 000 (with abstracts, summaries and graphics) = 15,35 sheet publications. CONTENT ABBREVIATIONS............................................................................................. 8 INTRODUCTION............................................................................................... 9 Modern principles of choice of impact zones in the physiotherapy treatment..... 10 Lets speak more detail on the possible areas of choice for PT................................ 10 Zones of Zakhary’in-Ged and metameric segmental principle of choosing zones in physiotherapy...................................................................... 11 The systemic principle of the human body functions organization and the selection of treatment zones, based on this principle.............................. 15 Special and specific zones of influence and choice in the practice of physical therapy............................................................................ 21 Lumbar region...................................................................................................... 21 The area of cervical spine...................................................................................... 21 The trans-cerebral techniques............................................................................... 22 Biological rhythms and bioresonance therapy...................................................... 26 Ultrasound therapy............................................................................................... 47 Basic terms and concepts...................................................................................... 49 Features of action of ultrasonic waves on the body............................................... 52 The therapeutic effect of ultrasound waves*........................................................ 53 The methods and techniques of treatment with ultrasonic waves........................ 57 Ultrasound therapy (UST).................................................................................... 58 Ultraphonophoresis (UPPh)................................................................................. 58 Sonopuncture (SP)............................................................................................... 61 A combination of other health factors with sonopuncture................................... 65 The combination of the action of ultrasonic waves with other physical factors ... 65 Indications and contraindications to the use of ultrasound therapy.............................................. 66 The main indications for ultrasound therapy........................................................ 66 Main contraindications......................................................................................... 67 Prohibited areas for ultrasonic therapy................................................................. 67 Features of ultrasound therapy............................................................................. 68 Nota bene for doctor and patient......................................................................... 69 Magnetic-laser therapy......................................................................................... 69 Therapeutic effects of magnetic laser therapy (MLT)........................................... 72 General principles of magneto-laser therapy........................................................ 78 Here are some options for MLT and features of their use.................................... 79 Percutaneous magnetic laser irradiation of blood................................................ 80 The zone for exposure to magnetic percutaneous laser irradiation of the blood . 82 Parameters of the procedure of hemo-magnetic-laser-therapy........................................................................... 82 The combined and united use of physical factors.................................................. 84 REFERENCES.................................................................................................... 88 PRACTICAL RECOMMENDATIONS FOR USE OF MAGNET-LASER-ULTRASOUND THERAPY IN CLINICAL PRACTICE AND THE SPA ................................................................................ Contraindications................................................................................................. 92 К00-К93 Diseases of the digestive system........................................................... 94 K50-K52 NONINFECTIOUS Enterocolitis and colitis...................................... 94 K29 GASTRITIS, DUODENITIS...................................................................... 96 K25 Gastric ulcer.................................................................................................. 98 K26 Duodenal Ulcer............................................................................................ 98 K71 LIVER TOXICITY..................................................................................... 100 К70 K70 CHRONIC HEPATITIS..................................................................... 102 К82.8 DYSKINESIA OF CYSTIC DUCT OR GALLBLADDER.................... 104 К 86.0 CHRONIC PANCREATITIS................................................................. 106 K81 CHOLECYSTITIS (non-calculous)............................................................ 108 К 59.0 CONSTIPATION (Other functional intestinal disorders)...................... 110 J00-J99 RESPIRATORY DISEASES............................................................................... 112 A15-A19 PULMONARY TUBERCULOSIS.................................................... 112 J42 CHRONIC BRONCHITIS UNSPECIFIED.............................................. 114 J18 PNEUMONIA............................................................................................. 116 J.45 BRONCHIAL ASTHMA............................................................................ 118 J01 ACUTE SINUSITIS (ANTRITIS)............................................................... 120 J01 ACUTE SINUSITIS (FRONTAL SINUSITIS)........................................... 122 J03 ACUTE TONSILLITIS................................................................................ 124 J00 ACUTE NASOPHARYNGITIS (RHINITIS)............................................. 126 J31.2 CHRONIC PHARYNGITIS.................................................................... 128 J37 CHRONIC LARYNGITIS AND TRACHEITIS......................................... 130 Н65- Н66 CHRONIC SUPPURATIVE OTITIS MEDIA................................ 132 H81.0 MÉNIÈRE’S DISEASE, SENSORINEURAL HEARING LOSS...................................... 134 K00-K14 DISEASES OF ORAL CAVITY,....................................................... 136 SALIVARY GLANDS AND JAWS......................................................................................... 136 М19.2- М24.6 ARTHROSIS OF THE TEMPOROMANDIBULAR JOINT..... 138 N00-N99 DISEASES OF THE GENITOURINARY SYSTEM........................ 140 F98 ENURESIS.................................................................................................. 140 N48.4 IMPOTENCE.......................................................................................... 142 N41.1 CHRONIC PROSTATITIS..................................................................... 144 N34 URETHRITIS AND URETHRAL SYNDROME...................................... 146 N11 CHRONIC PYELONEPHRITIS............................................................... 148 N20-N23 UROLITHIASIS................................................................................ 150 O00-O99 PREGNANCY, CHILDBIRTH AND THE PUERPERIUM........... 152 O92.1 CRACKED NIPPLES............................................................................. 152 MAIN POINTS OF ACUPUNCTURE IN GYNECOLOGY........................... 154 N61 MASTITIS................................................................................................. 154 N70.1 CHRONIC ADNEXITIS........................................................................ 156 N71 ENDOMETRITIS...................................................................................... 158 N94 ALGOMENORRHEA............................................................................... 160 N91.0- N91.1 AMENORRHEA........................................................................ 162 N73 INFLAMMATORY DISEASES OF THE PERITONEUM AND TISSUES OF THE SMALL PELVIS...................................................... 164 N86 CERVICAL EROSION............................................................................. 166 N90.5 KRAUROSIS OF THE VULVA.................................................................................. 168 N89 VAGINAL DISCHARGE......................................................................... 170 N97 INFERTILITY........................................................................................... 172 О12- О14- О15 GESTATIONAL TOXICOSIS (GESTOSES)......................... 174 I99 DISEASES OF THE CIRCULATORY SYSTEM................................ 176 I10 HYPERTENSIVE HEART DISEASE....................................................... 176 I22 MYOCARDIAL INFARCTION................................................................ 178 I49 EXTRASYSTOLE (OPTION 1).................................................................. 180 I49 EXTRASYSTOLE (OPTION 2).................................................................. 182 E10-E14 DIABETES.......................................................................................... 184 I20-I25 CORONARY HEART DISEASE........................................................ 186 E06.3 AUTOIMMUNE THYROIDITIS........................................................... 189 I63 ISCHEMIC STROKE................................................................................. 191 G43 MIGRAINE............................................................................................... 194 N00-H59 DISEASES OF THE EYE AND ADNEXA...................................... 196 H47.0 OPTIC NERVE SUBATROPHY.......................................................... 196 H35 RETINITIS PIGMENTOSA...................................................................... 196 H00-H59 MYOPIA............................................................................................ 198 Н 36.0 DIABETIC RETINOPATHY................................................................ 200 L00-L99 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE....... 203 L40 PSORIASIS................................................................................................ 203 L43 RED FLAT ZOSTER.................................................................................. 205 L20-L30 DERMATITIS AND ECZEMA......................................................... 207 B00 B00 INFECTION CAUSED BY THE HERPES VIRUS (HERPES SIMPLEX)........................................................................................ 210 L20.8 NEURODERMATITIS........................................................................... 212 L94.0 LOCALIZED SCLERODERMA............................................................ 214 SURGICAL DISEASES.................................................................................... 216 К65 PERITONITIS........................................................................................... 216 L91.0 KELOIDS (PREVENTION SUPPURATION)...................................... 218 T79.3 POST-TRAUMATIC WOUND INFECTION, NOT ELSEWHERE CLASSIFIED................................................................... 220 FESTERING WOUNDS................................................................................... 220 L02 ABSCESSES, BOILS, CARBUNCLES.................................................... 222 L03 PHLEGMON, FELON............................................................................... 222 E14.5 TROPHIC ULCERS................................................................................ 224 I80 PHLEBITIS AND THROMBOPHLEBITIS.............................................. 226 А46 ERYSIPELAS............................................................................................ 228 T20-T32 THERMAL AND CHEMICAL BURNS............................................ 230 M42 OSTEOCHONDROSIS............................................................................ 232 M54.4 4 LUMBAGO WITH SCIATICA.......................................................... 234 R52 CHRONIC PAIN SYNDROME................................................................ 236 M60.0 MYO FASCIITIS................................................................................... 238 M62.8 MIOFIBROZIT...................................................................................... 238 M79.0 FIBROSIS; FIBROMYALGIA;............................................................ 238 M72.5 FASCIITIS.............................................................................................. 238 M00-M99 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE......................................................... 240 M 00 - M 03 INFECTIOUS ARTHROPATHIES............................................. 240 M05-M14 INFLAMMATORY POLYARTHROPATHIES............................. 242 (RHEUMATOID ARTHRITIS)........................................................................ 242 М15-М 19 DEFORMING ARTHROSIS.......................................................... 244 М10-М14 ARTHRITIS GOUTY....................................................................... 246 K07 DISEASES OF THE TEMPOROMANDIBULAR JOINT....................... 248 K07.6 CALCANEAL SPUR.............................................................................. 250 М 65.2 CALCIFYING TENDOVAGINITIS................................................... 252 М45. BEKHTEREV’S DISEASE (ANKYLOSING SPONDYLITIS)............ 254 M24 DUPUYTREN’S CONTRACTURE......................................................... 256 M81 OSTEOPOROSIS...................................................................................... 258 G00-G99 DISEASES OF THE NERVOUS SYSTEM...................................... 260 G51 NEURITIS OF THE FACIAL NERVE..................................................... 260 G50 DAMAGE OF THE TRIGEMINAL NERVE........................................... 262 Ultrasound puncture........................................................................................... 264 М79.2 INTERCOSTAL NEURALGIA............................................................ 265 Ultrasound puncture........................................................................................... 267 M79.2 NEURALGIA OF CERVICAL DEPARTMENT OF THE BACKBONE .. 268 M79.2 NEURALGIA OF THE LUMBAR SPINE...................................................................................... 270 Т75.2 VIBRATION DISEASE.......................................................................... 272 M60 MYOSITIS................................................................................................. 274 ULTRASONIC PUNCTURE IN MYOSITIS:.................................................. 275 F00-F99 MENTAL AND BEHAVIORAL DISORDERS................................ 276 F51.0 INSOMNIA............................................................................................. 276 F32 DEPRESSION............................................................................................ 278 F40-F48 NEUROTIC, STRESS-RELATED AND SOMATOFORM DISORDERS........................................................................ 280 Е65-Е68 OBESITY AND OTHER TYPES OF HYPERNUTRITION............. 282 F01.1 MULTI-INFARCT DEMENTIA............................................................. 284 I 15 VEGETATIVE DYSTONIA (VD) ON HYPERTENSIVE TYPE............ 286 G21 PARKINSON’S DISEASE........................................................................ 288 F90 DYSTONIC HYPERKINESIA (TORTICOLLIS,.................................... 290 OROMANDIBULAR DYSKINESIA)............................................................. 290 APPLICATION OF MAGNET-LASER ULTRASOUND THERAPY FOR HEALTH IMPROVING AND PREVENTIVE PURPOSES 292 Annex 1..

    L-Valine derived chiral N-sulfinamides as effective organocatalysts for the asymmetric hydrosilylation of N-alkyl and N-aryl protected ketimines

    No full text
    L-Valine derived N-sulfinamides have been developed as efficient enantioselective Lewis basic organocatalysts for the asymmetric reduction of N-aryl and N-alkyl ketimines with trichlorosilane. Catalyst 3c afforded up to 99% yield and 96% ee in the reduction of N-alkyl ketimines and up to 98% yield and 98% ee in the reduction of N-aryl ketimines

    The vanishing author in computer-generated works: a critical analysis of recent Australian case law

    No full text
    Abstract The use of software is ubiquitous in the creation of many copyright works, yet the requirement in copyright law that every work have a human author who engages in independent intellectual effort means that its use may prevent copyright subsistence. Several recent Australian cases have refocused attention on authorship as an essential criterion of copyright subsistence, and these cases suggest that much computer-produced output may be authorless and thus lack copyright protection. This article, the first in a two-part series, analyses how each case deals with the question of authorship of computer-produced works and why the use of software diminishes copyright protection for a significant number of computer-generated works. The article critiques the application of conventional notions of human authorship developed in the pre-computer age to modern productions and suggests alternative approaches to authorship that satisfy both the major objectives of copyright policy and the need to adapt to the computer age. The article argues that, without a broader judicial approach to authorship of computer-generated works, Parliament must remedy the lacuna in protection for these ‘authorless’ works. Possible solutions for reform are suggested. In a forthcoming article, the author comprehensively examines those reform proposals
    corecore